Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
暂无分享,去创建一个
S. Piantadosi | J. Wingard | C. Civin | N. Gorin | H. Bonte | M. Stull
[1] J. Klein,et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. , 2000, The New England journal of medicine.
[2] S. Heimfeld,et al. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. , 2000, Blood.
[3] S. Singhal,et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial , 2000, The Lancet.
[4] T. Iwai,et al. Allogeneic peripheral blood stem cell transplantation in children with hematologic malignancies from HLA-matched siblings. , 2000, Medical and pediatric oncology.
[5] G. Hill,et al. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. , 2000, Transplantation.
[6] J. Bourhis,et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] K. Cleary,et al. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation , 1999, Bone Marrow Transplantation.
[8] K. Sullivan,et al. Pathophysiology and treatment of graft-versus-host disease. , 1999, Hematology/oncology clinics of North America.
[9] C. Civin,et al. Comparisons of alloreactive potential of clinical hematopoietic grafts. , 1999, Transplantation.
[10] P. Wernet,et al. Haematopoietic Transplant Potential of Unrelated and Related Cord Blood: The first six Years of the EUROCORD/NETCORD Bank Germany , 1999, Klinische Padiatrie.
[11] S. Cohen,et al. Analysis of the cytokine production by cord and adult blood. , 1999, Human immunology.
[12] P. Wernet,et al. Identification of cord blood dendritic cells as an immature CD11c- population. , 1999, Blood.
[13] F. Mandelli,et al. Umbilical cord blood transplant from unrelated HLA-mismatched donors in children with high risk leukemia , 1999, Bone Marrow Transplantation.
[14] C. Eaves,et al. Human growth factor-enhanced regeneration of transplantable human hematopoietic stem cells in nonobese diabetic/severe combined immunodeficient mice. , 1999, Blood.
[15] J. Adamson,et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. , 1998, The New England journal of medicine.
[16] M. Martelli,et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. , 1998, The New England journal of medicine.
[17] C. Civin,et al. In vivo engraftment potential of clinical hematopoietic grafts. , 1998, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[18] C. Civin,et al. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras. , 1998, Experimental hematology.
[19] K. Sullivan,et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. , 1997, Blood.
[20] J. Wagner,et al. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. , 1997, Blood.
[21] C. Eaves,et al. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[22] C. Eaves,et al. Sustained proliferation, multi‐lineage differentiation and maintenance of primitive human haemopoietic cells in NOD/SCID mice transplanted with human cord blood , 1997, British journal of haematology.
[23] C. Chastang,et al. Outcome of cord-blood transplantation from related and unrelated donors , 1997 .
[24] J. Dick,et al. Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. , 1997, Blood.
[25] Connie J. Eaves,et al. 4 Stem cell kinetics , 1997 .
[26] J. Dick,et al. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. , 1997, Blood.
[27] J. Briones,et al. Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood. , 1997, Blood.
[28] N. Schmitz,et al. Transplantation of peripheral blood progenitor cells from HLA‐identical sibling donors , 1996, British journal of haematology.
[29] W. Vainchenker,et al. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. , 1996, Blood.
[30] R. Storb,et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. , 1996, Blood.
[31] J. Wagner,et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. , 1996, Blood.
[32] I. Benet,et al. Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group. , 1996, Bone marrow transplantation.
[33] F. Benvenuto,et al. Thiotepa Cyclophosphamide Followed by Granulocyte Colony-Stimulating Factor Mobilized Allogeneic Peripheral Blood Cells in Adults With Advanced Leukemia , 1996 .
[34] A. Santoro,et al. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. , 1996, Bone marrow transplantation.
[35] J. Kurtzberg. Editorial: Umbilical Cord Blood: A Novel Alternative Source of Hematopoietic Stem Cells for Bone Marrow Transplantation , 1996 .
[36] J. Ferrara,et al. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. , 1995, Blood.
[37] J. Adamson,et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Dick,et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. , 1994, Blood.
[39] J. Kurtzberg,et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. , 1989, The New England journal of medicine.
[40] K. Sullivan,et al. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients , 1982 .
[41] R. Storb,et al. MARROW GRAFTS BETWEEN DL‐A‐MATCHED CANINE LITTERMATES , 1973, Transplantation.
[42] J. Even,et al. The Umbilical Cord Blood αβ T-Cell Repertoire: Characteristics of a Polyclonal and Naive but Completely Formed Repertoire , 1998 .
[43] G. Morgan,et al. Allogeneic peripheral blood stem cell transplantation for haematological malignancies – an analysis of kinetics of engraftment and GVHD risk , 1997, Bone Marrow Transplantation.
[44] M. Roncarolo,et al. Immune responses by cord blood cells. , 1994, Blood cells.
[45] J. Dick,et al. SCID mice as an in vivo model of human cord blood hematopoiesis. , 1994, Blood cells.